ipriflavone has been researched along with Cognitive Decline in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Nie, R | 1 |
Lu, J | 1 |
Xu, R | 1 |
Yang, J | 1 |
Shen, X | 2 |
Ouyang, X | 1 |
Zhu, D | 1 |
Huang, Y | 1 |
Zhao, T | 1 |
Zhao, X | 1 |
Lu, Y | 1 |
Qian, M | 1 |
Wang, J | 1 |
1 other study available for ipriflavone and Cognitive Decline
Article | Year |
---|---|
Ipriflavone as a non-steroidal glucocorticoid receptor antagonist ameliorates diabetic cognitive impairment in mice.
Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Humans; Isoflavones; Mice; Phosphat | 2022 |